Skip to main content
NRXP
NASDAQ Life Sciences

NRx Subsidiary GeNeuro Wins European Patent for ALS Drug Candidate GNK-301

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.4
Mkt Cap
$147.206M
52W Low
$1.62
52W High
$5.055
52W Position info
110% above low
Off High info
33% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

NRXP has more than doubled off its 52-week low of $1.62 on light trading volume (0.4× avg).

Summary

GeNeuro, an NRx subsidiary, secured a European patent (EP 3 570 878 B1) covering GNK-301, a monoclonal antibody targeting HERV-K envelope protein implicated in ALS. The patent adds to two existing US patents and strengthens IP protection for a program that has shown neurotoxicity-blocking effects in preclinical models. GNK-301 is now in cGMP manufacturing with Phase 1 trials planned for H2 2027. This follows GeNeuro's August 2026 selection in the CDMRP ALS grant competition, signaling continued momentum in the ALS pipeline. For a company with a $147M market cap and a going concern warning, a new patent and advancing clinical program provide a meaningful, if early-stage, positive development.

At the time of this announcement, NRXP was trading at $3.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $147.2M. The 52-week trading range was $1.62 to $5.06. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NRXP - Latest Insights

NRXP
Nov 17, 2026, 7:18 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.10
Real-time Price: $2.71 info
Change: +$0.610 (+29%) info
Market Cap: $120.794M info
NRXP
Oct 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $2.71 info
Change: -$0.2698 (-9%) info
Market Cap: $120.794M info
NRXP
Oct 15, 2026, 8:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.55
Real-time Price: $2.71 info
Change: +$0.160 (+6%) info
Market Cap: $120.794M info
NRXP
Oct 05, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.86
Real-time Price: $2.71 info
Change: -$0.150 (-5%) info
Market Cap: $120.794M info
NRXP
Sep 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.98
Real-time Price: $2.71 info
Change: -$0.2745 (-9%) info
Market Cap: $120.794M info